Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis Giulia RonconiLetizia DondiNello Martini Original Research Article 25 May 2021 Pages: 595 - 604
Prehospital Adenosine Diphosphate Receptor Blocker Use, Culprit Artery Flow, and Mortality in STEMI: The MADDEC Study Markus HautamäkiLeo-Pekka LyytikäinenJussi Hernesniemi Original Research Article Open access 08 June 2021 Pages: 605 - 613
Spontaneous and Immune Checkpoint Inhibitor-Induced Autoimmune Diseases: Analysis of Temporal Information by Using the Japanese Adverse Drug Event Report Database Keiko OgawaYoshihiro KozukaRumiko Hosoki Original Research Article 10 June 2021 Pages: 615 - 627
A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV Randolph P. MatthewsDeanne Jackson RuddMarian Iwamoto Original Research Article Open access 21 June 2021 Pages: 629 - 638
Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects Ashit TrivediMia MackowskiEdward Lee Original Research Article 10 June 2021 Pages: 639 - 645
Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects Ashit TrivediRajneet K. OberoiEdward Lee Short Communication 07 June 2021 Pages: 647 - 652
Successful Intravenous Thrombolysis and Endovascular Treatment for Acute Ischemic Stroke in a Patient Pretreated with Ticagrelor: A Case Report and Literature Review Federica RizzoDomenico Maria MezzapesaMarco Petruzzellis Research Letter 09 June 2021 Pages: 653 - 657
Comment on ‘Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety’ Andrew KorenAndreas KarasRoger Echols Letter to the Editor Open access 26 May 2021 Pages: 659 - 660
Response to “Comment on: Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety” Young R. Lee Letter to the Editor 10 June 2021 Pages: 661 - 662
Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction Anthony J. Accurso Letter to the Editor 14 June 2021 Pages: 663 - 664
Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence Joao P. De AquinoSuprit ParidaMehmet Sofuoglu Letter to the Editor 09 June 2021 Pages: 665 - 665